Association of PON1 and PON2 Polymorphisms with PON1 Activity and Significant Coronary Stenosis in a Tunisian Population

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochemical Genetics

• Publication date

  2012-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10528-012-9544-yPMID 23053877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis

  2012cited by this paper
• Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis

  2011cited by this paper
• Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.

  2011cited by this paper
• The three-gene paraoxonase family: physiologic roles, actions and regulation.

  2011cited by this paper
• PON1 55 and 192 Gene Polymorphisms in Type 2 Diabetes Mellitus Patients in a Turkish Population

  2011cited by this paper
• The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study

  2010cited by this paper
• Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease: Impact of a High-Density Lipoprotein–Bound Antioxidant in Secondary Prevention

  2010cited by this paper
• Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids.

  2010cited by this paper
• Metabolic Syndrome Is a Risk Factor for Coronary Artery Disease in a Tunisian Population

  2010cited by this paper
• HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis.

  2010cited by this paper
• The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population.

  2010cited by this paper
• Paraoxonases: structure, gene polymorphism & role in coronary artery disease.

  2009cited by this paper
• Paraoxonase Gene Polymorphism in South-western Korean Population

  2009cited by this paper
• Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.

  2009cited by this paper
• A preliminary study of human paraoxonase and PON 1 L/M55–PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease

  2009cited by this paper
• Measurement of serum paraoxonase-1 activity in the evaluation of liver function.

  2009cited by this paper
• Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

  2008cited by this paper
• Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population.

  2008cited by this paper
• The paraoxonase gene polymorphism in stroke patients and lipid profile

  2008cited by this paper
• Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.

  2008cited by this paper
• [Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction].

  2008cited by this paper
• The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese

  2008cited by this paper
• Association of cys 311 ser polymorphism of paraoxonase-2 gene with the risk of coronary artery disease.

  2008cited by this paper
• Asociación de los polimorfismos de la paraoxonasa 1 y la paraoxonasa 2 con el riesgo de infarto agudo de miocardio

  2008cited by this paper
• Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis.

  2007cited by this paper
• Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians

  2007cited by this paper
• Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.

  2006cited by this paper
• Paraoxonase gene polymorphisms and haplotype analysis in a stroke population

  2006cited by this paper
• Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins

  2006cited by this paper
• Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease

  2005cited by this paper
• SNPAnalyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis

  2005cited by this paper
• Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke

  2005cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• The paraoxonase‐2‐310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus

  2005cited by this paper
• PON1 M/L55 mutation protects high-risk patients against coronary artery disease.

  2004cited by this paper
• Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction

  2004cited by this paper
• Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Antioxidant paraoxonase 1 activity in the metabolic syndrome.

  2003cited by this paper
• PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease.

  2003cited by this paper
• The paraoxonase gene family and coronary heart disease

  2002cited by this paper
• Human Paraoxonase1 Gene Polymorphisms and the Risk of Coronary Heart Disease: A Community-Based Study

  2002cited by this paper
• Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.

  2002cited by this paper
• PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population

  2002cited by this paper
• Paraoxonase and Atherosclerosis

  2001cited by this paper
• Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype?

  2001cited by this paper
• Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

  2001cited by this paper
• A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms.

  2001cited by this paper
• Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.

  2000cited by this paper
• Tobacco Smoking Modifies Association Between Gln-Arg192 Polymorphism of Human Paraoxonase Gene and Risk of Myocardial Infarction

  2000cited by this paper
• Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.

  2000cited by this paper
• Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.

  2000cited by this paper
• Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

  2000cited by this paper
• Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

  1999influential reference
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

  1997cited by this paper
• Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.

  1997influential reference
• Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols.

  1997cited by this paper
• Comparison of purified human and rabbit serum paraoxonases.

  1995cited by this paper
• The molecular basis of the human serum paraoxonase activity polymorphism

  1993cited by this paper
• Smoking influences the atherogenic potential of low-density lipoprotein

  1992cited by this paper
• Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking.

  1992cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Free-radical chemistry of cigarette smoke and its toxicological implications.

  1985cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Association of paraoxonase-1 (Q192R) gene polymorphism with coronary artery spasm during cardiac catheterisation in Egyptians

  2024cites this paper
• CDKN2B‐AS (rs2891168), SOD2 (rs4880), and PON1 (rs662) polymorphisms and susceptibility to coronary artery disease and type 2 diabetes mellitus in Iranian patients: A case‐control study

  2023cites this paper
• The associations of PON1 and APOE polymorphisms with plasma lipid levels and the risk for late complications in type 2 diabetes patients

  2023cites this paper
• Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease

  2022cites this paper
• Plasma cholinesterase activity is influenced by interactive effect between omethoate exposure and CYP2E1 polymorphisms

  2021cites this paper
• PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia

  2018cites this paper
• Association between dementia and vascular disease-associated polymorphisms in a Tunisian population

  2018cites this paper
• Paraoxonase 2 Cys311Ser polymorphism and its association with the systolic blood pressure values in asymptomatic dyslipidemic individuals: a pilot study

  2015cites this paper
• Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.

  2015cites this paper
• Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus

  2014cites this paper
• Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

  2014cites this paper